ЕРЛОТОКС

उत्पाद अवलोकन

About ЕРЛОТОКС

ЕРЛОТОКС is a prescription medication containing the active ingredient Erlotinib, a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by blocking the epidermal growth factor receptor (EGFR) tyrosine kinase, thereby inhibiting tumor growth and metastasis.

Key Benefits & Uses

• Treatment of non-small cell lung cancer (NSCLC) in patients with specific EGFR mutations
• Treatment of pancreatic cancer in combination with gemcitabine
• May be used in patients with locally advanced or metastatic NSCLC who have failed other treatments

Active Ingredient & Action

Erlotinib, the active ingredient in ЕРЛОТОКС, is a small molecule inhibitor that selectively targets the EGFR tyrosine kinase. By binding to the ATP-binding site of the EGFR, Erlotinib prevents the activation of downstream signaling pathways, ultimately leading to the inhibition of tumor cell proliferation and survival.

Important Notes

ЕРЛОТОКС is available in tablet form and should be taken orally once daily. It is essential to follow the prescribed dosage and schedule to minimize the risk of adverse effects. Patients should be monitored for signs of skin rash, diarrhea, and other potential side effects. Consult a healthcare professional for guidance on the safe use of ЕРЛОТОКС.